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The Ca2D-Induced Structural Changes in Troponin In-Situ and In-Vitro:
A FRET Study in Permeabilized Cardiac Muscle Fibers and Reconstituted
Thin Filaments
King-Lun Li1, John R. Solaro2, Wenji Dong1.
1Washington State University, Pullman, WA, USA, 2University of Illinois at
Chicago, Chicago, IL, USA.
Ca2þ binding to N-domain of cardiac troponin C (N-cTnC) initiates a cascade
of structural changes within the thin filament. Among these changes, Ca2þ-in-
duced structural changes in troponin play a critical role in the allosteric regu-
lation of the force-generating acto-myosin interactions. Although previous
in-vitro studies have provided insight into these structural changes, how they
are modulated by geometric and mechanical constraints conferred by the sarco-
meric lattice structure in muscle tissue remains unknown. Recently we have
developed a technique to quantitatively measure these structural changes in
chemically-skinned muscle fibers using time-resolved FRET. In this study,
we use this technique to monitor the Ca2þ-induced N-cTnC opening in skinned
muscle fibers and compare the obtained results to in-vitro studies. FRET
donor (AEDANS) and acceptor (DDPM) modified double-cysteine mutant
cTnC(13C/51C)AEDANS-DDPMwas reconstituted into skinned muscle fibers
to examine the N-cTnC opening. To study the effects of crossbridge and
sarcomere-length based activation on this structural change, simultaneous
measurements of fluorescence intensity decays and isometric tension were
performed. Our results show that at steady-state, the Ca2þ-induced N-cTnC
opening is proportional to muscle force development, but the level of opening
varies depending on the presence or absence of strong crossbridges (XB). For
instance, in the presence of sodium vanadate (inhibitor of XB) no Ca2þ-induced
force response was observed, but Ca2þ-induced opening of N-cTnC in the fi-
bers was evident but with a smaller magnitude. Furthermore, when compared
to in-vitro measurements, results from muscle fibers suggest that N-cTnC
may adopt a more compact structure in muscle fibers due to the constraints
imposed by the myofilament lattice structure. The effects of the myofilament
lattice structure on structural dynamics of N-cTnC are also discussed in terms
of FRET distance distributions.
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Characterization of a Cardiac Troponin C-Troponin I Chimera Protein
Sandra E. Pineda-Sanabria1, Olivier Julien2, Monica X. Li1,
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Association of the regulatory N-domain of cardiac troponin C (cNTnC) with
the switch region of cardiac troponin I (cTnI147-163) is a major step in Ca
2þ
regulation of myocardial contraction by troponin as it triggers a series of
downstream events that leads to contraction. Investigation of this interaction
in the presence and absence of ligands, including Ca2þ and cardiotonic drugs,
is important to understanding the regulation of cardiac contraction. This is
commonly studied in vitro using isolated cNTnC and cTnI147-163; however,
this does not accurately reflect the in situ environment since cNTnC and
cTnI147-163 are spatially confined in the myofibril by being attached to their
respective structural scaffold domains, the C-domain of cTnC (cCTnC) and
the troponin T binding region of cTnI (cTnI80-136). We have designed, ex-
pressed and characterized a cardiac chimera (cChimera) protein containing
cNTnC linked to cTnI144-173 through a linker containing a tobacco etch virus
or thrombin protease cleavage site (similar to skeletal chimera of Tiroli et al,
2005). Our results show that Ca2þ binding to cChimera (KD 0.15 5
0.05 mm) is tighter than to cNTnC (KD 2.6 5 0.1 mm) and to that observed
in skinned muscle fibers (KD 1.2 mm). We assessed binding of the calcium
sensitizer dfbp-o, and desensitizer W7, and show that cChimera is particularly
useful for studying and searching interactions of cNTnC-cTnI144-173 with
potential agonists. Our cChimera also facilitates the production of the switch
cTnI peptide using bacterial cultures by enzyme specific proteolysis after
expression along with cNTnC. The dynamic properties of cChimera, along
with Ca2þ and drug binding properties, make cChimera a convenient system
for the investigation of regulation of troponin by small molecules that target
the cTnC-cTnI interface.
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The troponin complex acts as a molecular switch in striated muscle cells to reg-
ulate myosin attachment to and isomerization on actin filaments. Transitions
between the inactive and active states of the cardiac thin filament require exten-
sive domain movements and binding exchanges involving the C-terminaldomain of cardiac troponin I (TnI-C, residues 130-210). Mutations in TnI-C
are associated with hypertrophic cardiomyopathy, highlighting the importance
of this domain in regulating cardiac contraction. However, the conformation
and dynamics of TnI-C are poorly characterized due to order/disorder transi-
tions between binding states, leaving mechanistic details undetermined for
both wild-type and diseased complexes. TnI-C is likely disordered in solution
and the unbound state [1], coupling binding and folding as it fly-casts onto its
actin/tropomyosin binding site to block myosin access to actin [2].
Here we use a combination of computational and experimental techniques to
probe the conformation and dynamics of TnI-C in its multiple binding states,
using pairwise fluorescence measurements applicable to both the solution-
state and the thin filament-docked complex. Our molecular dynamics simula-
tions are consistent with TnI-C disorder in the unbound state; simulations be-
ginning from a helical model unfold regardless of starting orientation or the
presence of the rest of the complex, and there is no consensus structure in
the disordered state over multiple 50 ns simulations of the free domain.
Remarkably, the presence of the N-terminal globular head of troponin C affects
TnI-C conformation in silico, emphasizing the importance of interdomain and
intermolecular interactions in the troponin complex.
1. Julien, O., Mercier, P., Allen, C.N., Fisette, O., Ramos, C.H.I, et al. (2011)
Proteins 79: 1240-1250.
2. Zhou, Z., Li, K-L, Riek, D. Ouyang, Y., Chandra, M., Dong, W.J. (2012)
J. Biol. Chem. 287(10): 7661-7674.
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Myofilament Ca2D Sensitivity in Transgenic Mice Containing D230N
Mutation in a-Tropomyosin
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The role of sarcomeric mutations in pathological cardiac-remodeling is not well
understood. Furthermore, the constant modulation of myofilament contractility
by post-translational modifications (PTM) of regulatory proteins, to adapt to
a frequently changing circulatory demand, adds to the complexity. Therefore,
we investigated how such a PTM in cardiac troponin I (cTnI) interacted with
D230N (a dilated cardiomyopathy-related a-tropomyosin mutation), to alter
the contractile properties of the myofilament. We reconstituted the pseudophos-
phorylated form of cTnI (cTnID23/D24) into detergent-skinned papillary muscle
fibers from non-transgenic (NTG) and transgenic D230N mice, to mimic
PKA-mediated phosphorylation in response to b-adrenergic stimulation. We
carried out mechanical and dynamic studies on cTnID23/D24-D230N and control
fibers at sarcomere length 2.3 mm. The pCa-tension relationship revealed that
cTnID23/D24 decreased the pCa50 (-log10 [Ca
2þ]free required for half maximal
activation) from 5.6150.02 to 5.3450.01 in NTG fibers and from
5.4950.02 to 5.2250.01 in D230N fibers. Thus, cTnID23/D24 uniformly de-
creased pCa50 by 0.27 pCa units in both NTG and D230N fibers. Interestingly,
D230N mutation also uniformly decreased pCa50 by 0.12 pCa units, regardless
of the phosphorylation status of cTnI. This indicates that cTnID23/D24 and
D230N act independently to exert an additive effect of decreasing myofilament
Ca2þ sensitivity. Therefore, under sub-maximal concentrations of Ca2þ, the
amount of force produced would be greatly impaired, resulting in systolic
dysfunction.
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We have previously shown that two specific regions (residues 1-43 and residues
44-73) in rat cardiac troponin T (RcTnT) have divergent effects on contractile
function against an a-myosin heavy chain (a-MHC) background (Mamidi
et al., Abstract: Biophys J , vol.100, Issue 3, p586a, 2010). Because the effects
of Tn isoforms are modulated by an interplay with MHC, we hypothesized that
the divergent effects of residues 1-43 and residues 44-73 in cTnT would be
further modulated by a shift in MHC isoform to b-MHC. This has a direct bear-
ing on understanding the effects of alterations in cTnT and MHC isoforms not
only in health but also in disease. We generated two recombinant mutants
(RcTnT1-43 and RcTnT44-73) by deleting residues 1-43 and 44-73 in RcTnT,
respectively. We studied contractile function by reconstituting RcTnT1-43 and
RcTnT44-73 recombinant proteins into detergent-skinned papillary muscle
fibers from normal rat hearts (a-MHC) and propylthiouracil-treated rat hearts
(b-MHC). Our data shows that functional alterations induced by RcTnT1-43
and RcTnT44-73 were different in a-MHC vs. b-MHC fibers. For example,
RcTnT1-43 decreased both Ca
2þ-activated maximal tension (by ~46%) and
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RcTnT1-43 modestly decreased maximal tension (by ~18%), with no effect on
Ca2þ-sensitivity in b-MHC fibers. Thus, the desensitizing effect of RcTnT1-43
was attenuated by b-MHC. Ca2þ-activated maximal tension data were sup-
ported by myofiber dynamic stiffness measurements. Another major finding
is that RcTnT44-73 abolished the sarcomere length-dependent increase in
Ca2þ-sensitivity in b-MHC, but not in a-MHC fibers. Thus, our data demon-
strates that the functional outcome of the N-terminus of cTnT is modulated
by the type of MHC isoform present.
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Smooth muscle is unique in its capability to maintain force for long periods of
time at low ATP (energy) consumption. This property, called the latch-state, is
hypothesized to occur due to the dephosphorylation of myosin while attached to
actin. Alternative theories have proposed that dephosphorylated-detached
myosin can also re-attach to actin and contribute to force maintenance. The
goal of this study was to investigate the role of calponin in regulating and
enhancing the binding force of unphosphorylated tonic muscle myosin to actin.
To confirm the calponin regulation of our actin filaments at physiological con-
centrations, we used the in-vitro motility assay to measure the rate (1/2max) of
actin propulsion by myosin. Our results showed a significant decrease in 1/2max
(from 0.5450.01 mm/s (mean5SE) in the absence to 0.4350.01 mm/s in the
presence of calponin). When calponin was phosphorylated, this inhibitory
effect was suppressed (0.5050.01 mm/s). To measure the force of binding
(Funb) of unphosphorylated myosin to actin, we used the laser trap assay.
Funb was normalized by the number of myosin molecules estimated per actin
filament length. Funb of unregulated actin (0.1250.01 pN; mean5SE) was sig-
nificantly increased in the presence of calponin (0.2050.02 pN). When calpo-
nin was phosphorylated, this enhancement was lost (0.1250.01 pN). To verify
whether this enhancement of Funb is due to cross-linking of myosinto actin by
calponin, we repeated the measurements at high [KCl], as the calponin affinity
for myosin decreases at high ionic strength. Indeed, the Funb, in presence of
calponin, obtained at a [KCl] of 25mM (0.2150.02 pN; mean5SE) was sig-
nificantly decreased at a [KCl] of 150mM, (0.1350.01 pN). These data dem-
onstrate that calponin enhances the force of binding of unphosphorylated
myosin to actin by cross-linking them together.
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Congenital contractures such as clubfoot are present in ~1/250 live births.
Several congenital contractures syndromes are caused by mutations in genes
that code for skeletal myofilament proteins, including MYH3 and MYH8.
Because embryonic (MYH3) and perinatal (MYH8) myosin heavy chains are
unique to the prenatal development of muscle, it is important to understand
the contractile properties of human embryonic (HE) myosin and human fetal
(HF) muscle to determine how mutations affect performance and development.
However, information on HF skeletal muscle function is lacking. We previ-
ously reported HE myosin crossbridge cycling (measured by in vitro motility)
was much slower that rabbit psoas (RP) myosin (Biophys. J. (2010), 98:542a).
Here we characterized the contraction and relaxation properties of HF muscle
using myofibril mechanics techniques. HF skeletal muscle and myofibrils were
isolated from a 15.4 week gestation fetus. During maximal calcium activation
(15C) HF myofibrils produced much lower force (FMAX=5.951.2mN/mm
2)
as compared to myofibrils from human adult (HA) skeletal muscle
(84534mN/mm2) or RP muscle (220540mN/mm2). Unlike control HA and
RP fibrils, no striation pattern was apparent for HF myofibrils, suggesting
that immature sarcomeres could explain the lower force production. HF myo-
fibrils had slower kinetics of force development (kACT=0.6650.1s
1) vs. HA
(7.556.3s1) and RP (5.750.5s1) myofibrils. The initial (slow) phase of re-
laxation upon return to low calcium solution was slower and prolonged
(kREL,SLOW=0.5950.22s
1; tREL,SLOW=174513ms) vs. HA (2.951.7s
1;
71518ms) or RP (2.150.4s1; 73514ms) myofibrils. The larger, faster phase
of relaxation was also slower (HF=1.550.2s1 vs. HA=1255s1 and
RP=2154s1). Our previous in vitro motility experiments indicated a similar
inhibition of filament speed by increasing [ADP] for HE and RP myosin, butthis was under low load, thus ongoing experiments will determine if ADP re-
lease is responsible for the slower kinetics of HF muscle. Funded by
F31AR06300(A.R.), 5K23HD057331(A.B.), HD048895(M.B., M.R.).
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The ATP-sensitive Kþchannels(KATP) has been proposed as a molecular sen-
sor of atrophy in skeletal muscle(Tricarico et al., 2010). In the present work we
evaluated the ‘‘in vitro’’ effects of staurosporine, a well known apoptotic agent,
on sarcolemmal KATP channels and on muscle proteins content and fibers di-
ameter in slow-twitch Soleus(SOL) and fast-twitch Exstensor Digitorum
Longus(EDL) and Flexor Digitorum Brevis(FDB) muscles of mice. The iso-
lated muscles and the single fibers were incubated with staurosporine (1 mg/
mL) for 1-6-24-48 hrs. alone or in combination with diazoxide(100 mM-
250 mM), a KATP opener, and the changes in the total proteins content, gene
expression, fibers diameter and KATP channel activity were evaluated. We
found that staurosporine blocks KATP channels in excised-patch experiments
being more effective in SOL rather than in EDL and FDB fibers. The toxin
also caused a reduction of the proteins content/muscle of 45%, 25% and
21% for SOL, EDL and FDB, respectively at 24 hrs. A time-dependent reduc-
tion of the diameter is observed following incubation of the fibers with staur-
osporine. An up-regulation of the atrogin-1 gene while a down regulation of
the KATP channel subunits genes is observed in SOL. The co-incubation of
the muscles with staurosporineþdiazoxide for 24 hrs. fully prevented the re-
duction of the fibers diameter and protein content, and reduction of the
KATP channel activity. Our data indicate that staurosporine blocks KATP
channels in skeletal muscle leading to muscle atrophy and these effects are
phenotype dependent.
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Huntington’s disease (HD) is caused by an expanded polyglutamine (Poly-Q)
repeat in the Huntingtin (HTT) protein. Beyond the brain, htt gene is also
expressed in skeletal muscle. Muscle atrophy is common in HD patients, likely
from accumulation of toxic amyloid. To explore the mechanism of Poly-Q-
induced skeletal muscle defects associated with HD-causing amyloid protein,
we expressed mutant HTT with short (Httex1-PolyQ25) and expanded
(Httex1-PolyQ72) Poly-Q exclusively in the Drosophila indirect flight muscle
(IFM). Expression of Httex1-PolyQ-72 in the IFM resulted in severe defects in
skeletal muscle function and ultrastructure. Progressive reduction in flight per-
formance was observed in 3-day and 3-week old flies (a 20% and 90% decrease
in flight index, respectively) compared to age matched Httex1-PolyQ-25 flies.
Further, 3-week old flies expressing Httex1-PolyQ-72 showed amyloid aggre-
gates, whereas expression of Httex1-PolyQ-25 was benign. At the ultrastruc-
tural level, the myofibrils of control IFM showed well-organized Z-bands
and M-lines, however, IFM of 3-week old flies expressing Httex1-PolyQ-72
showed severe ultrastructural deterioration with broken Z-disks, M-lines and
a loss of thick filaments. In addition to myofibril defects, abnormal vacuole-
like structures of various sizes and shapes containing mitochondrial remnants
were present. Mutant fibers also display rimmed vacuoles fused with additional
membranes, suggesting the formation of type 2 autophagic vacuoles. To further
explore the mechanism underlying the PolyQ-induced skeletal muscle defects,
we treated flies expressing Httex1-PolyQ-72 with rapamycin, a known suppres-
sor of mTOR. Rapamycin-treated flies expressing Httex1-PolyQ-72 showed
significantly improved flight function (a 30% increase in flight index) and im-
proved myofibril integrity (organized Z-bands and M-lines) compared to flies
expressing Httex1-PolyQ-72 without rapamycin treatment. Thus, we have
developed a novel Drosophila model to explore and suppress skeletal muscle
defects linked with HD-causing amyloid by modulating the TOR pathway.
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